Loading...
ABT-263 induces G(1)/G(0)-phase arrest, apoptosis and autophagy in human esophageal cancer cells in vitro
Both the anti- and pro-apoptotic members of the Bcl-2 family are regulated by a conserved Bcl-2 homology (BH3) domain. ABT-263 (Navitoclax), a novel BH3 mimetic and orally bioavailable Bcl-2 family inhibitor with high affinity for Bcl-xL, Bcl-2 and Bcl-w has entered clinical trials for cancer treatm...
Na minha lista:
| Udgivet i: | Acta Pharmacol Sin |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5719159/ https://ncbi.nlm.nih.gov/pubmed/28713162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.78 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|